These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16259158)

  • 1. The innovation process centre stage.
    Med Device Technol; 2005 Sep; 16(7):28-31. PubMed ID: 16259158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mind the (biomedical funding) gap.
    Klausner A
    Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055
    [No Abstract]   [Full Text] [Related]  

  • 3. Imagining the future: what will the medical technology field look like.
    Gieras I; Corzine J; Dreps D; Fraai M; Grimes S; Hertzler L
    Biomed Instrum Technol; 2008; 42(6):433-4, 436-40. PubMed ID: 19012450
    [No Abstract]   [Full Text] [Related]  

  • 4. Ireland: delivering today and tomorrow.
    Med Device Technol; 2007 Oct; 18(6):43. PubMed ID: 18078182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical entrepreneurism: the current opportunity in America.
    Lexa FJ
    J Am Coll Radiol; 2004 Oct; 1(10):762-8. PubMed ID: 17411697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The industry in Europe: more together than apart.
    Med Device Technol; 2005 Nov; 16(9):32, 34, 36-7. PubMed ID: 16438447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical technology in Ireland.
    O'Donnellan N
    Med Device Technol; 2004 Dec; 15(10):42-3. PubMed ID: 16225286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 9. 2006: a stellar year for financing.
    Lawrence S
    Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech IPOs--flop or pop?
    Jacobs T
    Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641
    [No Abstract]   [Full Text] [Related]  

  • 11. Juno's whopping $120 million success signals new investing style.
    Willyard C
    Nat Med; 2014 Jan; 20(1):4-5. PubMed ID: 24398948
    [No Abstract]   [Full Text] [Related]  

  • 12. Looking at US versus European exit opportunities.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294
    [No Abstract]   [Full Text] [Related]  

  • 13. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boutiques reborn in 2003.
    Surendran A
    Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical medical technology--a physician's task].
    von Mallek D
    Dtsch Med Wochenschr; 2013 Aug; 138(33):1664. PubMed ID: 23913353
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 18. 2007--a banner year for biotech.
    Lawrence S
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of private financing hobbles emerging biotech regions.
    Jia H; Jayarama KS; Astvatsaturyan M
    Nat Biotechnol; 2006 Jan; 24(1):7-9. PubMed ID: 16404378
    [No Abstract]   [Full Text] [Related]  

  • 20. The responsibilities of growing up.
    Nat Biotechnol; 2006 Mar; 24(3):225. PubMed ID: 16525362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.